{"version":"1.0","provider_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","provider_url":"https:\/\/www.izb-online.de\/en\/","title":"Taking away the tumor\u2019s camouflage","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1BHSyyy6pH\"><a href=\"https:\/\/www.izb-online.de\/en\/wir-entziehen-dem-tumor-die-tarnung\/\">Taking away the tumor\u2019s camouflage<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.izb-online.de\/en\/wir-entziehen-dem-tumor-die-tarnung\/embed\/#?secret=1BHSyyy6pH\" width=\"600\" height=\"338\" title=\"&#8220;Taking away the tumor\u2019s camouflage&#8221; &#8212; Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" data-secret=\"1BHSyyy6pH\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.izb-online.de\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/Bild-1_Titelstory_Rigontec-Tumor_beitragsbild_20171.jpg","thumbnail_width":900,"thumbnail_height":445,"description":"Over millions of years the body has developed a natural defense mechanism. If infected by viruses or bacteria our immune system reacts by mounting an immediate response. We harness this mechanism for cancer therapy by fooling the immune system in believing that danger threatens. Hence we convert \u201ccold\u201c tumors, which are not recognized by the immune system, into \u201chot\u201c tumors, marking them for attack by the immune system. This technology inaugurates a new generation of immunotherapies to fight cancer or infectious diseases. To date, Rigontec has received close to EUR 30 million in private capital. Dr. Christian Schetter, CEO of Rigontec, talks to Susanne Simon about the new technology and vision of the company."}